Literature DB >> 11756322

Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia.

Martin G Bischof1, Elisabeth Bernroider, Martin Krssak, Michael Krebs, Harald Stingl, Peter Nowotny, Chunlin Yu, Gerald I Shulman, Werner Waldhäusl, Michael Roden.   

Abstract

We tested the impact of long-term near normoglycemia (HbA(1c) <7% for >1 year) on glycogen metabolism in seven type 1 diabetic and seven matched nondiabetic subjects after a mixed meal. Glycemic profiles (6.2 +/- 0.10 vs. 5.9 +/- 0.07 mmol/l; P < 0.05) of diabetic patients were approximated to that of nondiabetic subjects by variable insulin infusion. Rates of hepatic glycogen synthesis and breakdown were calculated from the glycogen concentration time curves between 7:30 P.M. and 8:00 A.M. using in vivo (13)C nuclear magnetic resonance spectroscopy. Glucose production was determined with D-[6,6-(2)H(2)]glucose, and the hepatic uridine-diphosphate glucose pool was sampled with acetaminophen. Glycogen synthesis and breakdown as well as glucose production were identical in diabetic and healthy subjects: 7.3 +/- 0.9 vs. 7.1 +/- 0.7, 4.2 +/- 0.5 vs. 3.8 +/- 0.3, and 8.7 +/- 0.5 vs. 8.4 +/- 0.7 micromol x kg(-1) x min(-1), respectively. Although portal vein insulin concentrations were doubled, the flux through the indirect pathway of glycogen synthesis remained higher in type 1 diabetic subjects: approximately 70 vs. approximately 50%; P < 0.05. In conclusion, combined long- and short-term intensified insulin substitution normalizes rates of hepatic glycogen synthesis but not the contribution of gluconeogenesis to glycogen synthesis in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756322     DOI: 10.2337/diabetes.51.1.49

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.

Authors:  Kalliopi Azariadis; Nikolaos K Gatselis; George K Koukoulis; Georgios N Dalekos
Journal:  BMJ Case Rep       Date:  2019-03-20

3.  Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day.

Authors:  Mary Courtney Moore; Marta S Smith; Ben Farmer; Katie C Coate; Guillaume Kraft; Masakazu Shiota; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-04-17       Impact factor: 9.461

4.  Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance.

Authors:  Elisa Álvarez Hernández; Sabine Kahl; Anett Seelig; Paul Begovatz; Martin Irmler; Yuliya Kupriyanova; Bettina Nowotny; Peter Nowotny; Christian Herder; Cristina Barosa; Filipa Carvalho; Jan Rozman; Susanne Neschen; John G Jones; Johannes Beckers; Martin Hrabě de Angelis; Michael Roden
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

5.  Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

Authors:  Kitt Falk Petersen; Thomas B Price; Raynald Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

6.  Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study.

Authors:  K Chokkalingam; K Tsintzas; J E M Snaar; L Norton; B Solanky; E Leverton; P Morris; P Mansell; I A Macdonald
Journal:  Diabetologia       Date:  2007-07-18       Impact factor: 10.122

7.  Antidiabetic activity of mefloquine via GLP-1 receptor modulation against STZ-NA-induced diabetes in albino wistar rats.

Authors:  Mohd Nazam Ansari; Abdulaziz S Saeedan; Rajnish Kumar Yadav; Jitendra K Rawat; Swetlana Gautam; Manjari Singh; Manish Kumar; Subhadeep Roy; Gaurav Kaithwas
Journal:  3 Biotech       Date:  2018-05-04       Impact factor: 2.406

8.  Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjects.

Authors:  M G Bischof; V Mlynarik; A Brehm; E Bernroider; M Krssak; E Bauer; C Madl; M Bayerle-Eder; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

9.  Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.

Authors:  G Perseghin; G Lattuada; F De Cobelli; A Esposito; F Costantino; T Canu; P Scifo; F De Taddeo; P Maffi; A Secchi; A Del Maschio; L Luzi
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

10.  Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver.

Authors:  Marietta Stadler; Christian Anderwald; Giovanni Pacini; Stefan Zbýn; Miriam Promintzer-Schifferl; Martina Mandl; Martin Bischof; Stephan Gruber; Peter Nowotny; Anton Luger; Rudolf Prager; Michael Krebs
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.